Lupin Suprax Re-Launch Backed By 45 Ventiv Sales Reps
This article was originally published in The Pink Sheet Daily
Ventiv Health will provide Lupin Pharmaceuticals with 45 specialized sales representatives for the re-launch of the antibiotic Suprax (cefixime)
You may also be interested in...
The cephalosporin antibiotic Suprax (cefixime) is returning to the market after a one-year absence
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.